Alzheimer's - Dementia, Author Interviews, End of Life Care, JAMA, University of Pennsylvania / 30.04.2019
Some with Elevated Alzheimer’s Biomarkers Interested in Aid-in-Dying Information
MedicalResearch.com Interview with:
Emily Largent, PhD, JD, RN
Assistant Professor, Medical Ethics and Health Policy
Perelman School of Medicine
Leonard Davis Institute of Health Economics
University of Pennsylvania
MedicalResearch.com: What is the background for this study? What are the main findings?
Response: Public support for aid in dying in the United States is rapidly growing. As a result, we’re now seeing debates about whether to expand access to aid-in-dying to new populations – such as people with Alzheimer’s disease – who wouldn’t be eligible under current laws.
With those debates in mind, we asked currently healthy people who recently learned about their risk for developing Alzheimer’s disease dementia (i.e., due to the presence of amyloid, an Alzheimer’s disease biomarker) whether they would be interested in aid-in-dying.
Our findings suggest that about 20% of individuals with elevated amyloid may be interested in aid-in-dying if they become cognitively impaired.
(more…)